Share on LinkedInShare on LinkedIn

ARTICLE · 06 NOVEMBER 2026

Third-Party Releases: When Silence Is No Longer Consent (Video)

Lowenstein Sandler LLP
Lowenstein Sandler LLP
Contributor
Lowenstein Sandler LLP

Lowenstein Sandler LLP

Lowenstein Sandler LLP is a national law firm with over 400 lawyers based in New York, Palo Alto,...

View firm profile
Explore more from Lowenstein Sandler LLP

Following the Supreme Court's Purdue Pharma decision, bankruptcy courts are grappling with a critical question: what constitutes valid creditor consent for third-party releases? Recent decisions in Ebix, Smallhold, and Alkegen are establishing new boundaries, distinguishing between mere silence and affirmative participation in the voting process. The evolving framework presents both opportunities and challenges for restructuring professionals seeking to bind creditors through opt-out mechanisms.

United StatesInsolvency/Bankruptcy/Re-Structuring

1865434.jpg

In this episode of the “Lowenstein Bankruptcy Lowdown,” David M. Posner and Brent Weisenberg , Vice Chairs of Lowenstein’s Bankruptcy & Restructuring Department, continue their discussion of third-party releases following Purdue Pharma and examine how courts are approaching the question of creditor consent. They discuss the Ebix, Smallhold, and Alkegen decisions, including why silence alone is not sufficient to establish consent, how affirmative participation in the voting process may affect an opt-out mechanism, and the remaining challenge of addressing non-voting creditors.

Speakers:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from